AlzChem Group AG (ACT) — Capital Reinvestment Ratio
Latest as of December 2025:
4.54x
AlzChem Group AG (ACT) has a Capital Reinvestment Ratio of 4.54x as of December 2025, meaning it reinvests 5% of its operating cash flow (€21.52 Million) in capital expenditures (€97.79 Million). See ACT free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
4.54x
Capex / Operating Cash Flow
Operating Cash Flow
€21.52 Million
EUR
Capital Expenditures
€97.79 Million
EUR
Data as of
Dec 2025
Most recent filing
AlzChem Group AG Capital Reinvestment Ratio (2012–2025)
This chart tracks AlzChem Group AG's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for AlzChem Group AG (2012–2025)
Year-by-year Capital Reinvestment Ratio for AlzChem Group AG from 2012 to 2025. For live market cap and broader valuation context, see market cap of AlzChem Group AG.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.71x | €137.01 Million | €97.79 Million | ▲ +74.1% |
| 2024 | 0.41x | €105.15 Million | €43.10 Million | ▲ +44.9% |
| 2023 | 0.28x | €72.67 Million | €20.56 Million | ▼ -57.4% |
| 2021 | 0.66x | €43.02 Million | €28.54 Million | ▲ +12.1% |
| 2020 | 0.59x | €48.71 Million | €28.83 Million | ▼ -37.6% |
| 2019 | 0.95x | €43.63 Million | €41.38 Million | ▼ -18.1% |
| 2018 | 1.16x | €34.66 Million | €40.13 Million | ▲ +42.7% |
| 2017 | 0.81x | €30.66 Million | €24.88 Million | ▼ -100.0% |
| 2014 | 264799.09x | €140.11 | €37.10 Million | ▲ +23027514.6% |
| 2013 | 1.15x | €15.57 Million | €17.91 Million | ▲ +31.7% |
| 2012 | 0.87x | €20.71 Million | €18.08 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow